Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer
607.3500 4.30 (0.71%)
NSE May 19, 2025 15:31 PM
Volume: 2.2M
 

logo
Laurus Labs Ltd.
11 Jan 2019
607.35
0.71%
BOB Capital Markets Ltd.
TCS reported an in-line revenue performance in Q3FY19 with 1.8% QoQ CC (+12.1% YoY) revenue growth. Subcontracting costs increased 60bps QoQ amid onsite supply constraints, putting pressure on EBIT margins (90bps QoQ to 25.6% vs. +20bps expected). Management's double-digit revenue growth guidance for FY19 remains intact. TCS continues to be our preferred pick amongst IT large-caps we reiterate BUY and roll over to a Dec'19...
KRChoksey released a Accumulate report for Laurus Labs Ltd. with a price target of 687.0 on 30 Apr, 2025.
More from Laurus Labs Ltd.
Recommended